Taiwan FDA registration 25f3bde29cff363d44818ff3abab5224
Trinity Biotech XII coagulation factor deficiency plasma
TW: 崔尼蒂生技第XII凝血因子缺乏血漿
Taiwan·Risk Class 2·TRINITY BIOTECH PLC·Registered May 04, 2006 – May 04, 2011CancelledRegistration details
- Analysis ID
- 25f3bde29cff363d44818ff3abab5224
- Customs Code
- DHA00601654400
Company information
- Manufacturer
- TRINITY BIOTECH PLC
- Manufacturer Country
- Ireland
- Authorized Representative
- BioChain Co., Ltd.
Product details
- Intended Use
- The XII inhibitor in human plasma was quantified by immunodefactoring by coagulation method.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.7290 factor deficiency test
- Import Information
- import
Dates and status
- Registration Date
- May 04, 2006
- Expiry Date
- May 04, 2011
- Cancellation Date
- Nov 09, 2012
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Trinity Biotech XII coagulation factor deficiency plasma in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 25f3bde29cff363d44818ff3abab5224 and manufactured by TRINITY BIOTECH PLC. The authorized representative in Taiwan is BioChain Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices